PAVmed (PAVM) Return on Capital Employed (2022 - 2025)
Historic Return on Capital Employed for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to 0.66%.
- PAVmed's Return on Capital Employed changed N/A to 0.66% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.66%, marking a year-over-year change of. This contributed to the annual value of 12.51% for FY2024, which is 60400.0% up from last year.
- Latest data reveals that PAVmed reported Return on Capital Employed of 0.66% as of Q3 2025.
- PAVmed's Return on Capital Employed's 5-year high stood at 11.57% during Q3 2023, with a 5-year trough of 10.11% in Q1 2023.
- In the last 4 years, PAVmed's Return on Capital Employed had a median value of 0.66% in 2025 and averaged 0.24%.
- Its Return on Capital Employed has fluctuated over the past 5 years, first surged by 137100bps in 2024, then plummeted by -47300bps in 2025.
- PAVmed's Return on Capital Employed (Quarter) stood at 4.14% in 2022, then soared by 200bps to 4.14% in 2023, then surged by 57bps to 6.49% in 2024, then plummeted by -110bps to 0.66% in 2025.
- Its last three reported values are 0.66% in Q3 2025, 0.77% for Q2 2025, and 1.2% during Q1 2025.